The CMS has made a concession in the transition to ICD-10. For a year past the Oct. 1 deadline, the CMS will pay for wrongly coded claims if the bad code is in the same broad family as the right one. That may be why the American Medical Association now says it will help get providers on board.
A number of states still do not report required quarterly data about services provided to Medicaid beneficiaries enrolled in managed care—information that's crucial to running Medicaid and protecting it from fraudsters, according to a study HHS' Office of Inspector General released Monday.
Revenue-cycle management and claims clearinghouse services provider Emdeon has inked a deal to acquire Altegra, a purveyor of healthcare consumer engagement technology for payers and self-insured employers.
Two out of three healthcare information technology leaders in a recent survey said they experienced a “significant” data security incident in the past year and cited medical identify theft as the biggest motivating factor.
Dr. Emad Rizk made $20.6 million in his first year as CEO of Accretive Health, nursing back to health a Chicago company reeling from controversy.
The average price providers paid for digital mammography systems was up 22% between February and April compared with the same period last year, fueled by increasing interest in 3D systems, according to the Modern Healthcare/ECRI Institute Technology Price Index.
Stephen Zieniewicz has been named president and CEO of St. Barnabas Medical Center in Livingston, N.J., a part of West Orange, N.J.-based Barnabas Health.
Aetna's proposed $37 billion offer for Humana is about building strength and scale in the government insurance business, but some investors are nervous about whether the parties can deliver on expectations.
Cardinal Health has completed its acquisition of The Harvard Drug Group, the Dublin, Ohio-based pharmaceutical and medical products distributor announced Monday.
Patients of a Detroit-area doctor received "stunning" doses of a powerful, expensive drug, exposing them to life-threatening infections, an expert testified Monday as a judge heard details about a cancer specialist who fleeced insurance companies and harmed hundreds of people.
Ascension CEO Anthony Tersigni shrugs off pending and possible deals between large insurers. The system, he says, is preparing to take on risk itself for self-insured employers.
Five people have been sent to federal prison for their roles in a $25 million Medicare fraud scheme that involved people from Nicaragua and the Dominican Republic posing as U.S. patients.